Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.

Journal of the National Cancer Institute - 5 Aug 1992

Li F P, Garber J E, Friend S H, Strong L C, Patenaude A F, Juengst E T, Reilly P R, Correa P, Fraumeni J F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Genetic Diseases, Inborn
Share to Li-Fraumeni Syndrome
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Pilot Projects

Share to Risk Assessment

Source

Identifiers

PMID: 1635084
DOI: 10.1093/jnci/84.15.1156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.PMID 1635084Read ↗

Somatic TP53 variants frequently confound germ-line testing resultsSemantic proximity Read ↗

Management of Cancer Genetic Testing: A Brief Overview.Semantic proximity Read ↗

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.Semantic proximity Read ↗

Sensitivity and predictive value of criteria for p53germline mutation screeningSemantic proximity Read ↗

Cancer risks from germline p53 mutations.Semantic proximity Read ↗

Predictive testing for germline mutations in the p53 gene: are all the questions answered?Semantic proximity Read ↗

Are we any closer to genetic testing for common malignancies?Semantic proximity Read ↗

Clinical guideline variability in the diagnosis and care of people at risk for hereditary hematopoietic malignancy syndromesSemantic proximity Read ↗

Germline vs. Somatic Genetic Testing: Their Increasing Use and Application.Semantic proximity Read ↗

Clinical management of TP53 mosaic variants found on germline genetic testingSemantic proximity Read ↗

The differential diagnosis of a TP53 genetic testing result.Semantic proximity Read ↗

Genetic testing for cancer predisposition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.